Stefan K.f. Schwabe, Executive Vice President R&D at SUPERNUS PHARMACEUTICALS INC (SUPN), sold 2,350 shares at $21.20 ($50K) on 2015-07-28, disclosed to the SEC on 2015-07-29.
Scheduled sale ($50k) by Executive Vice President R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.20 | 1,700 | $36K | 72.3% |
| 2 | $21.21 | 650 | $14K | 27.7% |
| Total | $21.20 avg | 2,350 | $50K | 100% |
| Filing → |
| SUPN | SELL | 2018-06-19 | $3.3M | — | Filing → |
| SUPN | SELL | 2017-09-11 | $4.4M | — | Filing → |
| SUPN | SELL | 2015-07-29 | $37K | — | Filing → |